No connection

Search Results

CTM

BEARISH
$0.69 Live
Castellum, Inc. · AMEX
Target $3.5 (+407.0%)
$0.48 52W Range $1.56

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Apr 26, 2026
Market cap
$65.31M
P/E
N/A
ROE
-8.6%
Profit margin
-4.5%
Debt/Equity
0.03
Dividend yield
N/A

AI Analysis

AI-powered fundamental assessment

Confidence
85%
The deterministic health profile is severely compromised, highlighted by a Piotroski F-Score of 1/9, indicating critical financial weakness. While the company maintains a strong liquidity position (Current Ratio 4.40) and positive revenue growth (21.9%), these are offset by consistent net losses and a total lack of earnings beats. Bearish technical trends and aggressive insider selling further signal a lack of confidence in the short-to-medium term outlook.

Key Strengths

Very low leverage with a Debt/Equity ratio of 0.03
Strong short-term liquidity (Current Ratio 4.40, Quick Ratio 4.23)
Consistent revenue growth (21.9% YoY and 21.94% Q/Q)
Healthy Gross Margin of 36.64%
Low Price-to-Sales ratio (1.24) suggesting potential undervaluation of top-line revenue

Key Risks

Critical financial health as evidenced by a 1/9 Piotroski F-Score
Persistent lack of profitability (Negative Profit and Operating Margins)
Strong bearish insider sentiment with 8 sell transactions and 0 buys
Poor earnings track record with 0 beats in the last 4 quarters
Severe negative price momentum across all timeframes (1Y Change: -30.8%)

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
24
Weak
Value
40
Future
50
Past
20
Health
10
Dividend
0
AI Verdict
High Risk / Speculative
Key drivers: Piotroski F-Score 1/9, Consistent insider selling, Negative net income, Strong liquidity
Confidence
90%
Value
40/100

Valuation is difficult to anchor without positive earnings; trades on revenue multiples.

Positives
  • Low P/S ratio (1.24)
  • Reasonable P/B ratio (1.83)
Watchpoints
  • No P/E due to lack of earnings
  • No Graham Number available
Future
50/100

Growth is present in revenue but not yet translating to the bottom line.

Positives
  • Double-digit revenue growth
  • Positive YoY EPS growth (though from a negative base)
Watchpoints
  • Failure to meet earnings estimates
  • Negative operating margins
Past
20/100

Long-term price destruction and poor execution against estimates.

Positives
  • Recent shift toward positive EPS in latest quarters
Watchpoints
  • Negative 5Y, 3Y, 1Y, and 6M price performance
  • Consistent earnings misses
Health
10/100

Despite high liquidity, the operational health is failing according to deterministic scoring.

Positives
  • Extremely low debt
  • High current ratio
Watchpoints
  • Piotroski F-Score of 1/9
  • Negative ROE and ROA
Dividend
0/100

Non-dividend paying growth/turnaround play.

Positives
No standout positives identified.
Watchpoints
  • No dividend paid
  • 0/100 dividend strength

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$0.69
Analyst Target
$3.5
Upside/Downside
+407.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for CTM and closest competitors.

Updated 2026-04-24
CTM
Castellum, Inc.
Primary
5Y
-42.5%
3Y
-31.3%
1Y
-30.8%
6M
-29.1%
1M
-1.0%
1W
-5.5%
SOT
Sono-Tek Corporation
Peer
5Y
-2.8%
3Y
-16.4%
1Y
+13.3%
6M
+0.7%
1M
+1.7%
1W
+5.8%
ATH
Aether Holdings, Inc.
Peer
5Y
-5.4%
3Y
-5.4%
1Y
-5.4%
6M
-40.1%
1M
-10.4%
1W
-2.7%
MAP
WM Technology, Inc.
Peer
5Y
-98.1%
3Y
-45.0%
1Y
-64.3%
6M
-67.5%
1M
-45.2%
1W
-48.0%
AMP
AmpliTech Group, Inc.
Peer
5Y
-74.5%
3Y
-6.6%
1Y
+64.1%
6M
-36.8%
1M
-8.6%
1W
+0.8%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
N/A
Forward P/E
34.52
PEG Ratio
N/A
P/B Ratio
1.83
P/S Ratio
1.24
EV/Revenue
0.98
EV/EBITDA
-39.26
Market Cap
$65.31M

Profitability

Profit margins and return metrics

Profit Margin -4.54%
Operating Margin -11.07%
Gross Margin 36.64%
ROE -8.58%
ROA -4.41%

Growth

Revenue and earnings growth rates

Revenue Growth +21.9%
Earnings Growth N/A
Q/Q Revenue Growth +21.94%
Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
0.03
Low debt
Current Ratio
4.4
Strong
Quick Ratio
4.23
Excellent
Cash/Share
$0.16

Financial Statement Flow

Interactive flow visualization showing how money moves through the company Q4 2025

Revenue
$0.0B
Gross Margin
33.9%
Op. Margin
-11.1%
Net Margin
-10.5%
Total Assets
$0.0B
Liabilities
$0.0B
Equity
$0.0B
Debt/Equity
0.17x
Operating CF
$-0.0B
CapEx
$-0.0B
Free Cash Flow
$-0.0B
FCF Yield
101%

Quarterly Earnings History

EPS performance vs analyst estimates

2026-03-09
$0.01
2026-02-27
$N/A
2025-11-07
$0.01
2025-08-08
$0.01

Technology Sector Comparison

Comparing CTM against 542 companies in the Technology sector (46 bullish, 183 neutral, 313 bearish)
Return on Equity (ROE)
-8.58%
This Stock
vs
-35.44%
Sector Avg
-75.8% (Below Avg)
Profit Margin
-4.54%
This Stock
vs
-12.42%
Sector Avg
-63.5% (Weaker)
Debt to Equity
0.03
This Stock
vs
0.7
Sector Avg
-95.1% (Less Debt)
Revenue Growth
21.9%
This Stock
vs
4573.41%
Sector Avg
-99.5% (Slower)
Current Ratio
4.4
This Stock
vs
3.64
Sector Avg
+20.8% (Stronger)

Similar Companies

Peer comparison within the same industry

Recent Insider Trading

Insider buy and sell transactions from the last 6 months

MARTIN TAMMY L
General Counsel
Stock Award
2026-03-31
1,329 shares · $783
BELL DAVID T
Chief Financial Officer
Stock Award
2026-03-31
1,329 shares · $783
MERRIMAN ANDREW
Chief Operating Officer
Stock Award
2026-03-31
1,329 shares · $783
IVES GLEN R
Chief Executive Officer
Buy
2026-03-27
2,000 shares · $1,231
MERRIMAN ANDREW
Chief Operating Officer
Buy
2026-03-27
2,000 shares · $1,285
IVES GLEN R
Chief Executive Officer
Buy
2026-03-26
10,000 shares · $6,649
MCMILLEN CHARLES THOMAS
Director
Sell
2026-03-25
30,000 shares · $21,129
MCMILLEN CHARLES THOMAS
Director
Sell
2026-03-18
55,000 shares · $44,099
MERRIMAN ANDREW
Chief Operating Officer
Buy
2026-03-18
3,000 shares · $2,395
WRIGHT JAY O
General Counsel
Sell
2025-12-19
30,000 shares · $31,500
WRIGHT JAY O
General Counsel
Sell
2025-12-16
18,000 shares · $19,494
WRIGHT JAY O
General Counsel
Sell
2025-12-12
188,000 shares · $224,088
WRIGHT JAY O
General Counsel
Sell
2025-12-01
53,000 shares · $55,740
WRIGHT JAY O
General Counsel
Sell
2025-11-17
100,000 shares · $115,060
WRIGHT JAY O
General Counsel
Sell
2025-11-13
220,000 shares · $257,200
Insider transactions can signal confidence or concerns about company prospects

SEC Filings

Recent regulatory filings from the SEC EDGAR database

8-K
8-K
2026-04-23

CTM filed an 8-K on April 23, 2026, likely to announce its first-quarter financial results.

DEF 14A
DEF 14A
2026-04-07

CTM filed a definitive proxy statement on April 7, 2026, providing shareholders with the necessary information to vote on corporate matters.

10-K
10-K
2026-03-09

CTM filed its annual 10-K report on March 9, 2026. While the filing contains sections dedicated to business operations, risk factors, and management's discussion and analysis, no specific financial highlights or risk details were provided in the available excerpts.

8-K
8-K
2026-03-05
8-K
8-K
2026-02-17

CTM filed an 8-K on February 17, 2026, likely to announce its annual financial results.

8-K
8-K
2026-01-08
8-K
8-K
2026-01-02
8-K
8-K
2025-12-09
8-K
8-K
2025-11-13
10-Q
10-Q
2025-11-07

CTM filed its quarterly 10-Q report on November 7, 2025. While specific financial metrics were not provided in the excerpt, the filing includes a detailed section on Risk Factors under Item 1A.

8-K
8-K
2025-11-07
8-K
8-K
2025-10-31
8-K
8-K
2025-10-21
8-K
8-K
2025-10-14
8-K
8-K
2025-08-19
Data sourced from SEC EDGAR. AI summaries generated automatically.

Past News Coverage

Recent headlines mentioning CTM from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile